What is the Historical Analysis of the Percutaneous Mechanical Circulatory Support Devices Market Size?
The percutaneous mechanical circulatory support devices market has seen considerable growth due to a variety of factors.
• In recent times, the market size for percutaneous mechanical circulatory support devices has seen a significant surge. The market, which stands at $2.26 billion in 2024, is predicted to increase to $2.48 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.0%.
The growth experienced in the historical period can be traced back to a variety of factors, including the rising prevalence of cardiovascular ailments, an increase in the elderly population, growing incidents of heart attacks, burgeoning awareness and screening initiatives, as well as heightened demand for heart pump devices.
What is the Forecasted Market Size and CAGR for the Percutaneous Mechanical Circulatory Support Devices Market?
The percutaneous mechanical circulatory support devices market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations are high regarding the robust expansion of the percutaneous mechanical circulatory support devices market in the coming years. The projections quantify this growth to hit $3.60 billion by 2029, tracking a compound annual growth rate (CAGR) of 9.7%.
Factors such as the increasing need for long-duration mechanical circulatory support, escalating healthcare expenditures, growing diabetic and obese demographics, a surge in the requirement for heart transplants, and an uptick in the approval of percutaneous procedures drive this growth. Forecast trends encompass improvements in pump technology, breakthroughs in the medical technology field, cardiac support technologies, minimally invasive medical procedures, and the evolution of biocompatible materials.
What Are The Key Drivers Fueling Growth In The Percutaneous Mechanical Circulatory Support Devices Market?
The surge in cardiovascular diseases is anticipated to drive the expansion of the percutaneous mechanical circulatory support devices market. Cardiovascular diseases, a collection of disorders impacting the heart and blood vessels, include conditions like coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. The rising prevalence of these conditions can be linked to factors such as an aging demographic, poor lifestyle choices, obesity, hypertension, and a genetic disposition. Percutaneous mechanical circulatory support devices are employed in the management of cardiovascular disorders to enhance cardiac functionality, lessen heart strain, and aid recovery in severe heart situations. For example, the Australian Institute of Health and Welfare, an Australian government agency, reported in December 2023 that the number of doctor-certified deaths due to coronary heart disease increased to 14,100 in 2021 and jumped to 14,900 in 2022. Consequently, the growing incidence of cardiovascular diseases is fueling growth in the percutaneous mechanical circulatory support (MCS) devices market.
What are the Market Segments in the Percutaneous Mechanical Circulatory Support Devices Market?
The percutaneous mechanical circulatory support devices market covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
Pre-Book The Percutaneous Mechanical Circulatory Support Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Percutaneous Mechanical Circulatory Support Devices Market Size?
In the percutaneous mechanical circulatory support devices market, leading companies are striving to develop technologically superior solutions like intra-aortic axial-flow devices to improve patient results and reduce surgical complications. These centric devices are aimed at augmenting blood flow from the left ventricle to the aorta, aiding in heart function. For example, in February 2023, Procyrion, Inc., an American medical device firm, publicized the successful inaugural use of its Aortix pump in humans. This groundbreaking device is made to prevent acute kidney injury in patients experiencing cardiac surgery. Inserted through a catheter into the descending thoracic aorta, the Aortix pump boosts renal perfusion and diminishes the pressure on the heart during operation. It manages this by enhancing both renal and general perfusion while simultaneously diminishing heart strain, proving exceptionally beneficial for patients with impaired left ventricular function and renal impairment. With the ability to provide up to 5.0 liters of flow each minute, the Aortix pump is designed for temporary use in procedures like percutaneous coronary interventions (PCI).
Who Are the Key Players in the Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are include:
• Abbott Laboratories
• Medtronic Plc
• Getinge AB
• Teleflex Incorporated
• Biotronik
• Abiomed Inc.
• LivaNova Plc
• Bioventrix
• Berlin Heart
• Eurosets
• Magenta Medical Ltd
• SynCardia Systems LLC
• CardiacAssist Inc.
• Jarvik Heart Inc.
• Procyrion
• BiVACOR Inc.
• CardioBridge GmbH and Company
• Circulite Medical Inc.
• NovaPump GmbH
• Supira Medical Inc.
• Pulsatile Technologies Inc.
What are the Regional Insights into the Percutaneous Mechanical Circulatory Support Devices Market?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
